Abbott splits to set pharma portfolio free
Friday, October 21, 2011 - 08:10
in Mathematics & Economics
US drug maker divides the firm into two parts as part of a rebalancing strategy
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via